Riot Platforms, Inc. — Director's Dealing 2012

May 18, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AspenBio Pharma, Inc. (APPY)
CIK: 0001167419
Period of Report: 2012-05-02

Reporting Person: Lundy Steve (Director, President, CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-05-02	Stock Option (Right to Buy)	$11.40	J	37658	Disposed	2020-03-24	Common Stock (37658)	Direct
2012-05-02	Stock Option (Right to Buy)	$2.95	J	5563	Disposed	2021-01-05	Common Stock (5563)	Direct
2012-05-02	Stock Option (Right to Buy)	$3.40	J	12834	Disposed	2021-07-08	Common Stock (12834)	Direct

Footnotes

F1: These stock options were transferred to the reporting person's ex-spouse pursuant to a final divorce decree.

F2: The transferred stock options to purchase 37,658 shares of common stock became exercisable as to 10,000 of the shares on May 5, 2010, as to 13,334 of the shares on March 24, 2011, as to 12,278 of the shares on March 24, 2012, and shall become exercisable as to 2,046 of the shares on March 24, 2013.

F3: The transferred stock options to purchase 5,563 shares of common stock became exercisable as to 3,000 of the shares on January 5, 2012, and shall become exercisable as to 1,538 of the shares on January 5, 2013, and as to 1,025 of the shares on January 5, 2014.

F4: The transferred stock options to purchase 12,834 shares of common stock shall become exercisable as to 7,000 on July 8, 2012, as to 3,500 of the shares on July 8, 2013, and as to 2,334 of the shares on July 8, 2014.